Organon & Co | OGN - Activos Circulantes





Activos Circulantes Cambio Fecha
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Celltrion KRW 5.54T 291.68B 2025-09
Cspc Pharmaceutical CNY 22.61B 721.94M 2025-06
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 413.82M 150.22M 2025-09
Divis Laboratories Ltd INR 98.43B 2.38B 2025-09
Gilead Sciences USD 19.89B 1.05B 2025-12
Glaxosmithkline GBP 23.98B 6.31B 2025-09
Kangmei Pharma CNY 7.03B 128.34M 2025-09
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Merck USD 47.56B 10.49B 2025-09
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Novartis USD 28.2B 2.26B 2025-09
Organigram Holdings CAD 284.9M 7.11M 2025-09
Organon & Co USD 4.7B 82M 2025-09
Ovoca Bio EUR 4.96M 2.06M 2022-06
Pharma Mar EUR 283.41M 40.53M 2025-12
Qiagen NV USD 2B 535.87M 2025-12
Sartorius EUR 1.72B 449M 2025-09
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tilray USD 688.63M 2.34M 2025-03